|
A/G Ratio |
>1 |
|
Albumin |
|
Men-Women |
3.8-5.0 g/dl |
|
Pregnancy
|
1.9-4.0 g/dl |
|
|
Alkaline Phosphatase
|
|
Men |
20-70 U/L |
|
Women
|
20-150 U/L |
|
Pregnancy |
60-200 U/L |
|
|
Amylase
|
|
Men |
50-150 U/L |
|
Women
|
60-180 U/L |
|
Pregnancy |
90-350 U/L |
|
|
AST
|
|
Men |
8-20 µ/L |
|
Women
|
6-18 µ/L |
|
Children |
25-75 µ/L |
|
|
Bilirubin
(total) |
0.2-1.0 mg/dl |
|
Bilirubin
(Indirect or Unconjugated) |
0.2-0.8 mg/dl |
|
Bilirubin
(Direct or Conjugated) |
0-0.2 mg/dl |
|
Bleeding time |
|
Earlobe
(Duke) |
< 8
minutes |
|
Forearm (Ivy) |
<9.5
minutes |
|
|
BUN |
|
Adults |
8-23 mg/dL |
|
Children
|
5-15 mg/dL |
|
Pregnancy |
5-12 mg/dL |
|
|
Calcium |
|
Men |
8.8-10.0 mg/dl |
|
Women
|
9.0-10.5 mg/dl |
|
Pregnancy |
8.1-9.5 mg/dl |
|
Children |
9.2-11.0 mg/dl |
|
|
Chloride |
|
Men |
98-106 mmol/L |
|
Women
|
98-106 mmol/L |
|
Pregnancy |
93-100 mmol/L |
|
|
Cholesterol:
Total |
|
Desirable |
140-200 mg/dl |
|
Borderline |
201-239 mg/dl |
|
High |
>240 mg/dl |
|
|
Cholesterol:
HDL |
|
Men |
35-70 mg/dl |
|
Women |
35-85 mg/dl |
|
Children |
30-65 mg/dl |
|
|
Cholesterol:
LDL |
|
Desirable |
<130 mg/dl |
|
Borderline |
130-159 mg/dl |
|
High |
>= 160 mg/dl |
|
|
Cholesterol:
VLDL |
25-50% of Total
Cholesterol |
|
CO2
Content |
|
Men |
23-30 mmol/L |
|
Women |
21-30 mmol/L |
|
Pregnancy |
18-25 mmol/L |
|
|
CPK
(CK) |
|
Men |
5-100 IU/L |
|
Women
|
10-70 IU/L |
|
Pregnancy |
5-40 IU/L |
|
|
Creatinine |
|
Men |
0.6-1.2 mg/dl |
|
Women |
<1.5 mg/dl |
|
Pregnancy |
<1.0 mg/dl |
|
Children |
0.3-0.7 mg/dl |
|
|
Creatinine Clearance |
|
Men |
70-130 ml/min |
|
Women |
91-130 ml/min |
|
Pregnancy |
120-160 ml/min |
|
|
DHEAS |
|
Men |
80-640 µg/dl |
|
Women
|
< 350 µg/dl |
|
Women: Moderate Increase
|
350-700 µg/dl |
|
Women: High Levels
|
> 700 µg/dl |
|
|
Estradiol |
|
Men |
13-42 pg/ml |
|
Women
(Proliferative Phase)
|
60-250 pg/ml |
|
Women
(Luteal Phase) |
75-450 pg/ml |
|
Women
(Menopausal) |
<10 pg/ml |
|
Women
(Menopausal on estrogen replacement)
|
50-100 pg/ml |
|
|
FSH |
|
Men |
4-25 mIU/ml |
|
Women |
4-30 mIU/ml |
|
Women (Midcycle) |
2 x baseline |
|
Women (Menopausal) |
40-250 mIU/ml |
|
|
FTI |
|
Men |
1.3-4.2 |
|
Women |
1.75-4.95 |
|
|
Glucose
- Fasting |
|
Men |
70-110 mg/dl |
|
Women
|
75-115 mg/dl |
|
Pregnancy
|
60-105 mg/dl |
|
|
Glucose:
2 Hour Post Prandial |
<140 mg/dl |
|
Glucose:
Pregnancy Screening |
|
Post 50 G Glucose Load |
<135 mg/dl |
|
|
Glucose:
Gestational Diabetes Criteria |
Post 100 G Glucose Load
|
Fasting |
95 mg/dl |
|
1-Hour
|
180 mg/dl |
|
2-Hour
|
155 mg/dl |
|
3-Hour
|
140 mg/dl |
If two or more of these values are exceeded,
gestational diabetes is present.
|
|
Hepatitis
B Surface Antigen |
Negative |
|
LDH |
|
Men |
95-200 U/L |
|
Women
|
200-450 U/L |
|
Pregnancy |
200-450 U/L |
|
|
LH |
|
Men |
7-24 mIU/ml |
|
Women
(Follicular Phase) |
6-30 mIU/ml |
|
Women
(Midcycle) |
>3x baseline |
|
Women
(Menopausal) |
>30 mIU/ml |
|
|
Magnesium |
|
Men |
1.7-2.8 mg/dl |
|
Women |
2-3 mg/dl |
|
Pregnancy
|
1.6-2.1 mg/dl |
|
Therapeutic Range in Pre-eclampsia
|
4-7 mEq/L |
|
|
Phosphorus |
|
Men |
2.7-4.5 mg/dl |
|
Women
|
3.0-4.5 mg/dl |
|
|
Platelets |
150,000-350,000/cu. mm |
|
Potassium |
|
Men |
3.5-5.0 mEq/L |
|
Women
|
3.5-5.0 mEq/L |
|
Pregnancy
|
3.3-4.1 mEq/L |
|
|
Pregnancy Test |
Negative |
|
Prolactin |
|
Men |
<20 ng/ml |
|
Women |
2-15 ng/ml |
|
Pregnancy
|
50-400 ng/ml |
|
|
Protein
(Total) |
|
Men-Women |
3.8-5.0 g/dl |
|
Pregnancy
|
3.0-4.0 g/dl |
|
|
PT |
|
Men-Women |
10-14 seconds (100%) |
|
Therapeutic Range on oral anticoagulants
|
2-2.5 times normal,
but not >30 seconds |
|
|
PTT |
|
PTT |
30-45 seconds |
|
APTT |
16-25 seconds |
|
Therapeutic
Range on oral anticoagulants
|
2-2.5 times normal |
|
|
SGGT |
|
Men |
8-20 U/L |
|
Women |
4-18 U/L |
|
|
SGOT |
|
Men |
8-20 µ/L |
|
Women
|
6-18 µ/L |
|
Children |
25-75 µ/L |
|
|
SGOT |
|
Men |
7-17 U/L |
|
Women
|
0-35 U/L |
|
Pregnancy |
0-35 U/L |
|
|
Sodium |
|
Men |
135-138 mEq/L |
|
Women
|
136-145 mEq/L |
|
Pregnancy
|
130-140 mEq/L |
|
|
T3 |
|
Men |
120-195 ng/dl |
|
Women |
70-190 ng/dl |
|
Pregnancy |
100-220 ng/dl |
|
|
T4 |
|
Men |
5-12.5 µg/dl |
|
Women |
5-12 µg/dl |
|
Pregnancy |
10-17 µg/dl |
|
|
T7
(FTI) |
|
Men |
1.3-4.2 |
|
Women |
1.75-4.95 |
|
|
TSH |
|
Men |
0.5-6 mIU/L |
|
Women |
4-5 mIU/L |
|
|
Triglycerides |
|
Men |
40-160 mg/dl |
|
Women |
35-135 mg/dl |
|
Pregnancy |
<260 mg/dl |
|
Children |
30-138 mg/dl |
|
|
Uric Acid |
|
Men |
3.5-7.2 mg/dl |
|
Women
|
1.5-6.0 mg/dl |
|
Pregnancy
|
1.2-4.5 |
|
